• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Research Briefing on Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate (CAS: 1365272-32-7)

Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate (CAS: 1365272-32-7) has emerged as a compound of significant interest in the field of chemical biology and pharmaceutical research. This ester derivative, characterized by its unique fluorinated aromatic structure, has been the subject of recent investigations due to its potential applications in drug discovery and development. The compound's structural features, including the presence of two fluorine atoms and a methoxy group, suggest possible interactions with biological targets, making it a promising candidate for further study.

Recent studies have focused on the synthesis and characterization of Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate, with particular attention to its physicochemical properties and reactivity. Researchers have employed advanced spectroscopic techniques, such as NMR and mass spectrometry, to confirm the compound's structure and purity. These efforts are critical for ensuring the reliability of subsequent biological evaluations and for establishing a foundation for potential scale-up processes in pharmaceutical manufacturing.

In the context of drug discovery, Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate has been explored as a building block for the development of novel therapeutic agents. Its fluorinated aromatic core is of particular interest, as fluorine substitution is known to influence the pharmacokinetic and pharmacodynamic properties of drug molecules. Recent in vitro studies have investigated the compound's potential as a precursor for kinase inhibitors, with preliminary results indicating moderate activity against selected kinase targets. However, further optimization and structure-activity relationship studies are needed to enhance its potency and selectivity.

The metabolic stability and toxicity profile of Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate have also been subjects of recent research. Early-stage ADME (Absorption, Distribution, Metabolism, and Excretion) studies suggest that the compound exhibits reasonable metabolic stability in liver microsome assays, though its bioavailability and tissue distribution characteristics require further investigation. These findings are crucial for assessing the compound's potential as a drug candidate and for guiding future medicinal chemistry efforts.

From a synthetic chemistry perspective, novel routes for the preparation of Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate have been reported, with emphasis on improving yield and scalability. Recent publications describe optimized coupling reactions and purification methods that address previous challenges in the compound's synthesis. These advancements are particularly valuable for enabling larger-scale production, which would support more extensive biological testing and potential preclinical development.

Looking forward, research on Methyl 2-fluoro-4-(5-fluoro-2-methoxyphenyl)benzoate is expected to focus on expanding its applications in medicinal chemistry and exploring its potential as a versatile intermediate for diverse therapeutic compounds. The compound's unique structural features position it as an interesting case study in fluorinated drug design, with implications for understanding how specific substitutions influence biological activity. Continued investigation of this molecule may yield valuable insights for the development of new pharmaceutical agents targeting various disease pathways.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)